SynthesisFrontiers in endocrinology2026

Redefining evidence for teprotumumab in thyroid eye disease: an updated meta-analysis of efficacy and safety.

Rongjing Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.